# Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

> **NCT06238245** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Beijing 302 Hospital** · enrollment: 22 (estimated)

## Conditions studied

- Graft-versus-host Disease
- Hematological Malignancies

## Interventions

- **DRUG:** Cyclophosphamid

## Key facts

- **NCT ID:** NCT06238245
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-02-28
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06238245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06238245, "Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06238245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*